Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
The global automated nucleic acid extraction market size was valued at US$ 3.6 Bn in 2025 and is projected to reach US$ 11.7 ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
Guanidine is an organic compound primarily used as a denaturing reagent to disrupt the structures of proteins and nucleic ...
Zacks Small Cap Research on MSN
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations
YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial and development strategy. The ...
Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...
A research team at The University of Osaka revealed that the loss of heterochromatin can cause a chain reaction leading to ...
Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how ...
Researchers at Utah State University revealed new details about CRISPR immune system defenses, such as Cas12a3 systems, that ...
A nano-sized medicine boosts the anti-cancer immune response and eradicates tumors in mice. Researchers at Washington University School of Medicine in St. Louis, working with colleagues at ...
Researchers say discoveries could expand the CRISPR toolbox and lead to more efficient, rapid diagnostic tools for detecting COVID-19, influenza, and RSV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback